readthroughSign in
Nov 12, 2026Financing

Trinity Biotech gets lender waiver after missing cash covenant for three months

Perceptive Credit Holdings granted a liquidity covenant waiver through October 2026 as part of a fifth amendment to Trinity Biotech's credit agreement.

Trinity Biotech PLC and its U.S. subsidiaries entered a fifth amendment to their credit agreement with Perceptive Credit Holdings III, LP, dated November 6, 2026, according to a filing disclosing the deal. The amendment was executed among Trinity Biotech, Inc., Clark Laboratories, Biopool U.S., Primus Corporation, MarDx Diagnostics, Immco Diagnostics, and TRIB Biosensors Inc. as borrowers, along with Trinity Biotech plc as parent guarantor and Perceptive Credit Holdings III, LP as administrative agent.1

The amendment addresses a covenant breach. Under the existing credit agreement, the company's obligors were required to hold at least $1,000,000 in unrestricted cash from November 2025 through September 2026, rising to a $3,000,000 minimum from October 2026 onward.1 The company disclosed it was not in compliance with this minimum liquidity covenant for June, July and August 2026, and requested waivers covering those months plus September and October 2026.1 The lenders agreed to grant the waiver and the parties also agreed to amend other provisions of the existing credit agreement.1

The waiver does not eliminate the underlying requirement. The filing states the waiver applies solely to the specified liquidity breach and does not waive any other default, with the minimum liquidity covenant continuing in full force going forward.1

The amendment also restates the company's outstanding note. The note originally issued to Perceptive on December 22, 2025 and amended in April 2026, with an original principal amount of $96,161,421.33, was amended and restated under the new agreement.1

The filing requires Trinity Biotech to disclose the material terms of the transaction, including the amendment itself, in a Form 20-F or Form 6-K within two business days of signing.1 The credit agreement underlying this amendment was originally dated August 7, 2025, and has now been modified five times.

Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.